Delayed Graft Function: Clinical Trials

1 trial for Delayed Graft Function, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Delayed Graft Function: new trials by email Literature Review of Delayed Graft Function trials Research Report on Delayed Graft Function

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
Ravulizumab, Placebo - Delayed Graft Function, DGF
Phase 3RecruitingAlexion Pharmaceuticals, Inc.4502025-05-192026-06-18

Broader conditions

Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

ravulizumab (1)

Sponsors

Alexion Pharmaceuticals, Inc. (1)

Countries

Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Brazil (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Japan (1)  ·  Poland (1)  ·  Portugal (1)  ·  South Korea (1)  ·  Spain (1)